You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | 45.1% | n/a |
ROCE | 1.8% |
Latest | Forecast | |
---|---|---|
P/E | 30.0 | n/a |
PEG | 0.3 | n/a |
Price / Revenue | 13.6 | n/a |
Price / Book value | 0.5 |
Latest | Forecast | |
---|---|---|
Revenue | 78.7% | 0.0% |
PBT | 96.8% | n/a |
EPS | 97.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-03-31 | 35.71 | 7.46 | 1.13p | 184.1 | 19.0 | 10% | n/a | 0.0% |
2021-03-31 | 19.93 | -5.45 | -0.82p | -309.8 | 0.0 | n/a | n/a | 0.0% |
2022-03-31 | 25.39 | 15.54 | 2.31p | 69.3 | 0.0 | n/a | n/a | 0.0% |
2023-03-31 | 27.50 | 11.27 | 1.69p | 87.7 | -3.3 | -27% | n/a | 0.0% |
2024-03-31 | 49.14 | 22.18 | 3.33p | 36.9 | 0.0 | 2,297% | n/a | 0.0% |
Syncona upbeat on interim trial results at Beacon Therapeutics Sharecast News | 06 Dec |
---|---|
Syncona launches Slingshot platform with £12.5m investment Sharecast News | 14 Nov |
Syncona's Autolus gets FDA approval for leukaemia treatment Sharecast News | 11 Nov |
Transaction in Own Shares | 20-Dec-24 07:01 |
---|---|
Transaction in Own Shares | 19-Dec-24 07:01 |
Transaction in Own Shares | 18-Dec-24 07:01 |
Transaction in Own Shares | 17-Dec-24 07:01 |
Transaction in Own Shares | 16-Dec-24 07:01 |